Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine with Pazopanib in Leiomyosarcoma
NCT01442662Phase 2Completed
- Sponsor
- Unicancer
- Start
- Sep 2011
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in leiomyosarcoma (LMS), sponsored by Unicancer. Started Sep 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
leiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT01442662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442662.